Massih Ningarhari - Publications

Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 27, 2025

Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French Genomic Medicine Initiative.

Journal: Journal of hepatology

Published: October 17, 2025

Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French genomic medicine initiative.

Journal: Journal of hepatology

Published: October 17, 2025

Immune checkpoint inhibitors after liver transplantation: The role of immunosuppressive management.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: August 07, 2025

Life-threatening immune-related adverse events in the intensive care unit: a narrative review.

Journal: Intensive care medicine

Published: July 06, 2025

Feasibility and Effectiveness of Liver Transplantation following Immunotherapy in Patients with Hepatocellular Carcinoma.

Journal: Liver cancer

Published: April 03, 2025

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: The Blind Spot of HCC Management.

Journal: United European gastroenterology journal

Published: March 25, 2025

Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: August 15, 2024

Good outcome of liver transplantation in patients with pre-existing renal cell carcinoma.

Journal: Clinics and research in hepatology and gastroenterology

Published: December 12, 2023

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma.

Journal: Nature communications

Published: August 05, 2023

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.

Journal: The Lancet. Oncology

Published: June 12, 2023

Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case-control study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 07, 2023